Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance


Earlier studies have suggested that higher cellular levels of teniposide (VM-26) are required for the inhibition of growth in L1210/VM-26 sublines than in parental L1210 cells [8]. On the basis of this observation, we hypothesized that resistance to VM-26, which is partly attributed to multidrug resistance, also resulted in reduced formation of DNA lesions by the drug. In confirmation of this hypothesis, equitoxic concentrations of VM-26 produced fewer breaks in the DNA of LIa5μM cells, the prototype L1210/VM-26 subline, than in that of L1210 cells. Previously, potassium cyanide (KCN) and verapamil were shown to increase the levels of VM-26 in LIa5μM but not L1210 cells. These agents also selectively increased the formation of breaks in the DNA of LIa5μM but not L1210 cells. The DNA unknotting assay with phage P4 DNA indicated equivalent DNA type II topoisomerase activity in nuclear extracts of LIa5μM and L1210 cells. The factor that reduced the formation of breaks in cellular LIa5μM DNA by VM-26 provided less protection against equitoxic levels of doxorubicin, to which LIa5μM cells are crossresistant.

This is a preview of subscription content, log in to check access.


  1. 1.

    Capranico G, Dasdia T, Zunino F (1986) Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and-resistant P388 murine leukemia cells. Int J Cancer 37: 227

  2. 2.

    Capranico G, Riva A, Tinelli S, Dasdia T, Zunino F (1987) Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei. Cancer Res 47: 3756

  3. 3.

    Friedman CA, Kohn KW, Erickson LC (1975) DNA chain growth during replication of asynchronous L1210 cells. Alkaline sedimentation studies. Biochemistry 14: 4018

  4. 4.

    Gerlach JH, Kartner N, Bell DP, Ling V (1986) Multidrug resistance. Cancer Surv 5: 25

  5. 5.

    Kohn KW, Ewig RAG, Erickson LC, Zwelling LA (1981) Measurement of strand breaks and cross-links by alkaline elution. In: Friedberg EC, Hanawalt PC (eds) DNA repair: a laboratory manual of research techniques. Dekker, New York, p 379

  6. 6.

    Krishan A, Paika K, Frei E III (1975) Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. J Cell Biol 66: 521

  7. 7.

    Lee T, Roberts D (1984) Selection and characterization of L1210 sublines resistant to teniposide (VM-26). Cancer Res 44: 2981

  8. 8.

    Lee T, Roberts D (1984) Flux of teniposide (VM-26) across the plasma membrane of teniposide-resistant sublines of L1210 cells. Cancer Res 44: 2986

  9. 9.

    Liu LF, Davis JD, Calendar R (1981) Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases. Nucleic Acids Res 9: 3979

  10. 10.

    Long BH, Musial ST, Brattain MG (1984) Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM-26: a quantitative structure-activity relationship. Biochemistry 23: 1183

  11. 11.

    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193: 265

  12. 12.

    Minford J, Pommier Y, Filipski J, Zwelling LA (1986) Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry 25: 9

  13. 13.

    Misra NC, Roberts D (1975) Inhibition by 4′-demethyl-epipodophyllotoxin-9-(4,6,-0-2-thenylidene-β-D-glucopyranoside of human lymphoblast cultures in G2 phase of the cell cycle. Cancer Res 35: 99

  14. 14.

    Pastan I, Gottesman M (1987) Multiple-drug resistance in human cancer. N Engl J Med 316: 1388

  15. 15.

    Roberts D, Hilliard S, Peck C (1980) Sedimentation of DNA from L1210 cells after treatment with 4′-demethylepipodophyllotoxin-9-(4,6-0-2-thenylidene-β-D-glucopyranoside) or 1-β-D-arabinofuranosylcytosine or both drugs. Cancer Res 40: 4225

  16. 16.

    Roberts D, Yalowich J, Foglesong D, Ashmun R (1986) Teniposide-resistance is multifaceted in L1210 cells. Proc Am Assoc Cancer Res 27: 267

  17. 17.

    Roberts D, Lee T, Parganas E, Wiggins L, Yalowich J, Ashmun R (1987) Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells. Cancer Chemother Pharmacol 19: 123

  18. 18.

    Roberts D, Meyers MB, Biedler J, Wiggins LG (1988) Association of sorcin with drug resistance in L1210 cells. Cancer Chemother Pharmacol 23: 19

  19. 19.

    Ross WE (1985) DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol 34: 4191

  20. 20.

    Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466

  21. 21.

    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) Increased accumulation of vincristine and adriamycin in drug-resistant tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42: 4730

  22. 22.

    Van der Bliek AM, Meyers MB, BiedlerJL, Hes E, Borst P (1986) A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells is homologous to the calcium-binding light chain of calpain. EMBO J 5: 3201

  23. 23.

    Yalowich JC, Roberts D, Benton S, Parganas E (1987) Resistance to etoposide (VP-16) in human leukemia K562 cells is associated with altered DNA topoisomerase II (TOPO II) activity and rapid reversal of drug-induced DNA damage. Proc Am Assoc Cancer Res 28: 277

Download references

Author information

Correspondence to DeWayne Roberts.

Additional information

This work was supported by Research Project Grant CA 39426 and Cancer Center Support (Core) Grant CA 21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Roberts, D., Foglesong, P.D., Parganas, E. et al. Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance. Cancer Chemother. Pharmacol. 23, 161–168 (1989).

Download citation


  • Doxorubicin
  • Cyanide
  • Verapamil
  • Cellular Level
  • Multidrug Resistance